NASDAQ:OSIS

OSI Systems (NASDAQ: OSIS) Reports Strong Q4 Earnings Amidst Revenue Challenges and Strategic Growth

Font: Financial Modeling Prep  • Aug 20, 2026

Market Chart
  • OSI Systems (NASDAQ: OSIS) exceeded Q4 earnings per share (EPS) expectations, reporting $3.78 against an estimated $3.77.
  • Quarterly revenue of $484.06 million fell short of estimates, impacted by geopolitical conflicts, yet the company achieved record operating cash flow.
  • The company secured a significant $200 million contract with U.S. Customs and Border Protection and expanded its stock repurchase program, signaling management confidence.

OSI Systems (NASDAQ: OSIS) is a company that designs and manufactures specialized electronic systems. It operates in sectors including security, healthcare, and optoelectronics. A key part of its business is the Security division, which provides products like the Rapiscan® inspection systems used at borders and high-security locations.

On August 20, 2026, OSI Systems reported its Q4 financial results. The company announced an earnings per share (EPS) of $3.78, which slightly surpassed the market's expectation of $3.77. This performance contributed to what the company's CEO described as a strong year with record non-GAAP earnings per share.

However, OSI Systems' quarterly revenue of $484.06 million did not meet the estimated $529.72 million. The CEO noted that this shortfall was influenced by revenue challenges stemming from conflicts in the Middle East. Despite this, the company achieved record operating cash flow during the quarter.

Looking ahead, the Security division secured a five-year contract from U.S. Customs and Border Protection with a value up to $200 million, as highlighted by Business Wire. In a separate announcement, OSI Systems expanded its stock repurchase program, authorizing the buyback of an additional one million shares. This action often signals management's confidence in the company's future.

From an investment valuation standpoint, OSI Systems has a price-to-earnings (P/E) ratio of 23.60 and a price-to-sales (P/S) ratio of 2.01. The company's financial health shows a debt-to-equity (D/E) ratio of 1.12. Its liquidity, or ability to cover short-term bills, appears strong with a current ratio of 3.25.

Market Overview
HOWL
Werewolf Therapeutics, Inc.
$0.92
112.64%
KNRX
Knorex Ltd.
$0.42
26.45%
GOSS
Gossamer Bio, Inc.
$0.16
0.06%
IBIT
iShares Bitcoin Trust ETF
$43.98
6.75%
BITO
ProShares Bitcoin ETF
$10.49
6.97%
TSLL
Direxion Daily TSLA Bull 2X ETF
$9.87
11.09%
CAN
Canaan Inc.
$0.36
27.43%
MARA
Marathon Digital Holdings, Inc.
$11.21
0.54%
LGCL
Lucas GC Limited Ordinary Shares
$0.07
-19.40%
INTC
Intel Corp.
$90.17
-2.13%